Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)

Clinical trial NCT05401071 · RECRUITING

Trial details

NCT number: NCT05401071
Sponsor: Huashan Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Tuberculosis, Pulmonary

Start date: 2023-01-13
Primary completion: 2024-10-01
Enrollment: 2442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.